智通财经APP讯,巨星医疗控股(02393)发布截至2024年12月31日止年度业绩,该集团期内取得收益24.1亿元(人民币,下同),同比减少17.26%;归属于公司拥有人应占溢利9.22亿元,去年同期则归属于公司拥有人应占亏损1388.8万元;每股基本盈利39.53分。
公告称,业务毛利按年下降22.2%至3.99亿元(2023年:5.13亿元),业务毛利率由17.6%下降至16.6%,主要源于集团受到国家集采政策的影响。
智通财经APP讯,巨星医疗控股(02393)发布截至2024年12月31日止年度业绩,该集团期内取得收益24.1亿元(人民币,下同),同比减少17.26%;归属于公司拥有人应占溢利9.22亿元,去年同期则归属于公司拥有人应占亏损1388.8万元;每股基本盈利39.53分。
公告称,业务毛利按年下降22.2%至3.99亿元(2023年:5.13亿元),业务毛利率由17.6%下降至16.6%,主要源于集团受到国家集采政策的影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.